Lumexa Imaging Holdings, Inc. (LMRI) Current Ratio
- Current ratio · latest quarter: Value 1.44×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 1.44× | Current assets / current liabilities. $256.42M ÷ $178.35M ≈ 1.44× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 256.42M USD | Assets, Current |
| Current obligations | 178.35M USD | Liabilities, Current |
| Cash and equivalents | 69.70M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | |
| Inventory | (m) | |
| Payables | 27.06M USD | Accounts Payable, Current |
| Borrowing debt due within one year | 14.33M USD | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $256.42M | $178.35M | $69.70M | (m) | (m) | (m) | $27.06M | $14.33M | 1.44× |
| 2026-03-31 | $221.89M | $157.93M | $51.23M | (m) | (m) | (m) | $37.17M | $13.44M | 1.40× |
| 2025-12-31 | $227.26M | $179.19M | $58.83M | (m) | (m) | (m) | $44.86M | $13.11M | 1.27× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B |